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Summary 
Mouse mammary tumor virus is known to infect newborn mice via mother's milk. A proposed 
key step for viral spread to the mammary gland is by the infection of lymphocytes. We show 
here that although in suckling mice retroviral proteins are found in all epithelial cells of the 
gut, viral DNA is exclusively detectable in the Peyer's patches. As early as 5 d after birth the 
infection leads to a superantigen response in the Peyer's patches but not in other lymphoid organs 
draining the intestine. Viral DNA can be detected before the superantigen response and becomes 
first evident in the Peyer's patches followed by mesenteric lymph nodes and finally all lymphoid 
organs. 
M 
ouse mammary tumor virus (MMTV) is a milk-trans- 
mitted retrovirus (1). After crossing the gut the virus 
infects susceptible cells and ultimately the mammary gland 
(2). During lactation, large quantities of MMTV are secreted 
into milk, thus transmitting the infection to the offspring. 
To date, the absence of in vitro models for MMTV infec- 
tion has delayed the understanding of the identity of cells 
supporting viral replication and the early events in the host 
immune response. Therefore the infectivity in vivo has been 
established by the late (6 mo-1 yr) appearance of mammary 
tumors in susceptible strains of mice (3). Most mouse strains 
contain endogenous MMTV DNA which does not usually 
produce infectious viruses.  MMTV superantigen molecules 
are expressed by B cells after both infection by exogenous 
or expression by endogenous viruses (4-8). 
Superantigens are a class of molecules that interact with 
a large percentage of T  cells that share expression of partic- 
ular TCR V3 elements. They are encoded in an MMTV open 
reading frame (or  0  and it has been shown that a sequence 
polymorphism at the 3' end of off correlates with the TCR 
V3 specificity (9-13). The superantigen effect is an absolute 
requirement for the establishment of a productive infection 
(8,  14). 
In a previous study (7, 15) we have characterized MMTV 
(SW), an infectious virus which stimulates a strong T  and 
B cell superantigen response after systemic inoculation into 
naive adult mice. The responsive CD4 + T  cells in vivo ex- 
press TCR V136. BALB/c mice have three endogenous MMTV 
proviruses (Mtv-6, -8, and -9) which differ in both super- 
antigen TCR Vt3 specificity as well as in the nucleotide se- 
quence from MMTV(SW)  orf (4). 
Exploiting these differences we were able to analyze the 
site and kinetics of infection by the exogenous MMTV(SW), 
and the superantigen response in neonatal mice. In this study 
we find that MMTV infects the newborn mice through in- 
testinal epithelium. The infection first occurs in the Peyer's 
patches and stimulates superantigen-responsive T cells as early 
as 5 d after birth. Finally this study shows that after infection 
of Peyer's patch lymphocytes, systemic spread of the virus 
involves first mesenteric lymph nodes and then all lymphoid 
organs. 
Materials and Methods 
M~:~  BALB/c  mice were purchased  from Harlan Olac (London, 
UK). MMTV(SW)-infected mice were obtained from IFFA Credo 
(UArlabesque, France) and bred in our animal facility. BALB.D2 
Mls-1 mice were originally obtained from H. Festenstein (London 
Hospital Medical College, London, England) (16) and maintained 
in our animal facility. 
Isolation of  Neonatal  Lymphoid  Organs.  Mesenteric lymph nodes 
were dissociated  mechanically  and cells  were kept in RPMI medium 
supplemented with 0.1% BSA on ice until use. Peyer's patches of 
mice at different ages were removed surgically  under magnification, 
lightly minced, and subjected to collagenase digestion (Type IA; 
Sigma Chemical Co., St. Louis, MO) 5 mg/ml in RPMI for 30 
min at room temperature. Digested tissue was dissociated  by pipet- 
ting until homogenous cell suspensions were obtained. The sus- 
pension was added to 10 ml of ice-cold RPMI containing 0.1% 
BSA in a 15-ml conical tube (Falcon model 2095; Becton Dick- 
inson & Co., Mountain View, CA) and centrifuged at 700 g for 
3 rain. The pellet was resuspended and recentrifuged. The cells 
from the supernatants, almost flee of endothelial cells, were used 
for FACS  |  analysis (Becton Dickinson &  Co.). 
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anti-V~6 (44-22-1) (17) or anti-VB14 (14.2) (18) hybridoma super- 
natants foUowed  by FITC-conjugated goat anti-rat IgG or anti-rat 
IgM sera (Caltag Laboratories, San Frandsco, CA). As a third layer, 
PE-conjugated anti-CD4  (GK1.5, Becton Dickinson & Co.) was 
used. For analysis of B cells, the cells were stained with an FITC- 
conjugated goat anti-mouse Ig F(ab')2 fragment.  The cells were 
analyzed on a FACScan  |  (Becton Dickinson & Co.) after exclusion 
of dead cells using forward  and side scatter analysis. 
Statistical Analysis.  The statistical analysis and curve fitting were 
performed by Dr. Guy van Melh (Institut de Mrdicine sociale et 
prrventive, Universit6 de Lausanne). The control lymph nodes have 
a constant  level of TCR V/~6 expression with a mean of 10.0% 
and a SD of +_ 0.61%. The 99% t-prediction interval for a future 
observation was 8.4-11.8%. Thus, observations outside this range 
are significantly different from the control response. The VB6- 
response curve of MMTV(SW)-infected  mice was calculated using 
a bootstrap  analysis (19). 
PCR Analysis.  Tissues  used for the PCR were snap frozen and 
kept at -80~  Pools of four to six mice were used for each PCR 
experiment. DNA of the different organs was isolated by overnight 
digestion at 52~  in 100 mM Tris-HCl,  pH 8.0, 5 mM EDTA, 
150 mM NaC1, 0.1 SDS, containing  proteinase K  (100/xg/ml). 
Purified DNA (300 ng) was amplified using PCR with the fol- 
lowing oligonucleotides  which recognize  all the known orf se- 
quences:  5'  GATCGGATCCATGCCGCGCCTGCAGCAGA  3' 
(VJ77) and 5' GTGTCGACCCAAACCAAGTCAGGAAACCAC- 
TTG 3'(VJ71) )ridding a 1,200-bp product. Alternatively, the oli- 
gonudentide pair specific for MMTV(SW) 5' GATCGGATCCAT- 
GCCGCGCCTGCAGCAGA 3' (VJ77) and 5' GCGACCCCC- 
ATGAGTATATTTC 3'(VJ83), were used fielding a 766-bp product. 
40 cycles of amplification were performed as described (7, 15). 
In short, 300 ng of DNA were amplified in 2 mM dNTP, lx PCR 
buffer (20 ram Tris-HCl, pH 8.3, 50 mM KC1, 2 mM Mg2C1 and 
0.01% gelatin), 1/zM oligonucleotides, and 0.5 U Taq-polymerase 
(Perkin Elmer Corp., Norwalk, CT) with the cycling steps 1 min 
at 95~  1 min at 55~  and 1 min at 72~  Thereafter, the prod- 
ucts were separated on 1.5% agarose gels and analyzed by Southern 
blot analysis with MMTV(GR) LTR probe using  standard con- 
ditions. 
Histology.  The tissues from 10-d-old mice were quickly excised. 
After embedding in OCT (Miles Scientific, Naperville, IL) gut ep- 
ithelium containing a pair of  jejunal Peyer's  patches was snap frozen 
in liquid nitrogen--cooled isopenthane. Sections (7/~m) on s/lane- 
treated slides were air-dried, acetone-fixed, treated with 0.1% BSA- 
containing PBS, pH 7.4, and incubated with rabbit anti-gp52 poly- 
clonal serum obtained from Dr. P. Hainaut (University of Liege, 
Bdgium) (20). After washings, the labeling was revealed with a 
biotinylated donkey Ig anti-rabbit serum and streptavidin-FITC 
(Amersham International,  Amersham, Bucks, UK). Controls  in- 
cluded a rabbit anti-mouse secretory component (SC) serum and 
the gp52-preadsorbed anti-gp52 rabbit serum. For detection of B 
ceUs, an FITC-conjugated goat F(ab')z fragment specific for mouse 
Ig was used. 
Confocal Imaging.  Confocal microscopy  was performed on a con- 
focal microscope (model MtkC-600; Bio Rad Laboratories, Brussels, 
Belgium) mounted on a Zeiss Axiovert 35M microscope with a 
63  x  1.4 NA objective, zoom 2, and 1 sAcan with 7-10 frames 
per image. 
Results 
Viral Uptake by Epithelia in the Newborn Intestine.  Mucosa- 
associated lymphoid tissue has been proposed to be a portal 
of entry of many pathogens (21, 22). In the small intestine 
these specialized areas of antigen sampling called Peyer's patches 
are overlaid by the follide-associated epithelium (FAE). FAE 
consists of two distinct epithelial cell types, the M cells and 
the enterocytes. The enterocytes of the newborn ileum in- 
cluding the FAE, differ from their adult counterparts by their 
capacity to internalize proteins and accumulate them into a 
large supranudear  vacuole (23-25). 
To study the pattern  of MMTV uptake in the digestive 
tract of newborn mouse, the gut tissue from 10-d-old mice 
breast-fed continuously by MMYV(SW)-infected mothers was 
analyzed. Gut tissue containing a Peyer's patch was removed 
and frozen sections were prepared and immunolabeled with 
an antibody specific for the MMTV envelope protein gp52 
(20).  In the Peyer's patch, 81052 was seen in the FAE cells, 
which is consistent with previous observations (27), although 
it was not possible to identify the labeled cell types. The viral 
envelope protein accumulated beneath the epithelial lining 
in contact with Peyer's patch lymphocytes (Fig.  1 A). In the 
adjacent villi, the envelope protein was found in small apical 
vesicles and in the large vacuoles of the enterocytes (Fig.  1 
B). This intraceUular distribution was similar to that reported 
by others (26) and suggests a degradative pathway. There was 
a clear  gradient  in the villi,  with  a near complete absence 
of gp52 in the crypts (Fig. 1 B). The labeling using as a con- 
trol rabbit serum directed against mouse-free SC was restricted 
to the cell surface of the crypt enterocytes (Fig.  1 C).  No 
labeling was detected in the structures positive for 81052 (com- 
pare Fig.  1, B and C). In serial sections incubated with the 
gp52 preadsorbed anti-gp52 serum, the specific labeling dis- 
appeared (Fig.  1 F). 
Induction orb Cell Reorganization  by MMTV Infection.  In 
8-9-d-old mice fed by infected mothers, the size of the patches 
was on average three times that of control mice. The patches 
were removed and analyzed by immunohistology.  Sections 
with the largest cross section diameter chosen from MMTV 
(SW)-infected and noninfected control mice, were immuno- 
labeled  with  a  F(ab')2  fragment  specific  for  mouse  Ig. 
Whereas the B cell distribution in control mice fed by unin- 
fected BALB/c mothers was diffuse with little follicular or- 
ganization  (Fig.  1 D),  a striking  reorganization  of B cells 
was observed in MMTV(SW)-infected mice (Fig. 1 E). The 
proximity of viral material with B cells below the FAE may 
facilitate retroviral infection at this site. Around day 5 after 
birth,  when the MMTV(SW)-induced T  cell response be- 
came apparent,  control as well as experimental animals showed 
a drastic increase of the percentage of B cells in the Peyer's 
patches, from 10 to about 50% (data not shown). Currently 
we do not know whether this increase is due to maturation 
of the immune system which starts reacting to environmental 
antigens  or to a programmed  increase of B cells. 
Kinetics of Superantigen Response in Peyer's Patches of Neo- 
natalMice.  MMTV(SW) encodes the most potent superan- 
tigen activity among the known murine retroviruses  (15). 
The responding T  cells express TCR V~56. To establish the 
time course of MMTV(SW) superanfigen-induced T cell ac- 
tivation in Peyer's patch and mesenteric lymph nodes durin~ 
the neonatal period of suckling mice, we performed FACS  | 
1512  Retroviral  Infection of Neonatal Peyer's Patch Lymphocytes Figure  1.  Morphology of ileal villi and Peyer's patches of newborn mice fed on MMTV-infected mothers. Frozen sections (7 #m) of ileal intestinal 
tissue containing one Peyer's patch from 10-d-old mice were stained with rabbit serum directed against the envelope protein gp52 (A and B), the same 
anti-gp52 serum preadsorbed with gp52 (F), and anti-mouse SC rabbit serum as a control (C') followed by a biotinylated donkey anti-rabbit Ig antibody, 
or with FITC conjugated goat F(ab')2 fragment specific for mouse Ig (D and E). (A-C) Confocal microscopy; (D-F) epifluorescence microscopy.  (A) 
Peyer's patch (PP). gp52-reactive material is seen beneath the follicle-associated epithel/um (FAE) (arrows)  in the dome region of the lymphoid follicle. 
Adjacent villi (V) are labeled and most of the lumen (L) is free of reactive material,  x450.  (/3) Ileal villi, gp52-reactive  material is detected in the 
apical and supranudear region of the enterocytes.  Note the absence of labeling in the crypt enterocytes,  x 250.  (C) Ileal villi. Sections were incubated 
with the rabbit anti-SC serum (C) and revealed with the same secondary antibody used for gp52 staining.  The labeling is restricted to the enterocytes 
in the crypt. Note that the structures that are labeled with anti-gp52 antibodies are not stained with the anti-SC antibody,  x250. (D) Peyer's patch 
follicle from control mice. The surface Ig + B cells form small aggregates in the Peyer's patch. The intensively stained Ig-producing plasma cells are 
present in the lamina propria of the adjacent ~li.  x 185. (E) Peyer's patch from mice fed on infected mothers. The surface Ig + B cells are organized 
in follicles in the Peyer's patch,  x185.  (F) Ileal villi. Sections were incubated with gp52 preadsorbed anti-gp52 and processed as in C. Note the structures 
labeled with the anti-gp52 antibody (A and B) are almost unstained,  x 130. 
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Figure  2.  Kinetics of the local immune response towards the MMTV 
(SW) superantigen. Peyer's patches as well as the mesenteric lymph nodes 
were tested for Vfl6  expression.  The  mice were fed continuously by 
MMTV(SW)-secreting mothers. Single cell suspensions were analyzed by 
FACS  |  for TCR  Vfl6 expression  in the CD4 +  population. Only the 
results for Peyer's patches are shown since the other lymph nodes did not 
show significant  increases of the percentage  of T  cells expressing  Vfl6. 
The percentage of other Vfl such as Vf114 did not change in these experi- 
ments (data not shown). Each symbol represents an experiment with a 
pool of four to six mice. (O) Results obtained from uninfected BALB/c 
mice;  (0)  percentages  of Vfl6 +  CD4 +  T  cells of infected  mice.  The 
horizontal parallel lines indicate a 99%  prediction interval for a future 
observation (• 3 SD). The 99.9th percentile of the first detectable MMTV 
(SW) immune response is reached by day 5. The 0.1th percentile of falling 
back to Vfl6 control levels is on day 16. The 99th percentile of falling 
below control levels occurs on day 48. The x-axis is shown in log scale. 
shown), we never observed any increase of Vfl6 + T cells but 
found that they started decreasing  after 3-4 wk. The per- 
centage of T  cells expressing  TCR Vf114 did not change. 
Similar experiments using MMTV(C3H) did not result in 
a significant increase of the responding Vf114  + T cells in the 
same investigated tissues (data not shown), in agreement with 
the above cited study on peripheral injection of MMTV(C3H) 
into adult naive mice (15). 
PCR Analysis of the Route of Infection and Systemic Spread. 
To detect viral DNA, we used oligonucleotides specific for 
MMTV(SW) as well as oligonucleotides able to amplify en- 
dogenous as well as exogenous viruses (15). Using a semi- 
quantitative PCR strategy with MMTV(SW)-specific primers, 
we detected neither amplification of MMTV(SW) RNA nor 
amplification products from BALB/c DNA. At different time 
points we removed Peyer's patches,  small intestine mucosa 
freed from Peyer's patches, mesenteric lymph nodes, spleen, 
peripheral lymph nodes, thymus, and mammary glands, and 
analyzed the levels  of endogenous  Mto or MMTV(SW) DNA. 
As can be seen in Fig. 3, MMTV(SW) DNA was exclusively 
detectable  in Peyer's patches of infected mice at day 4 and 
9 after birth.  After 14 d, a signal became apparent in the 
mesenteric lymph nodes and later all the tested lymphoid 
organs were positive for MMTV(SW) DNA. At early time 
points no MMTV(SW) DNA was detected in the gut epi- 
thelial tissue when Peyer's patches were removed, despite the 
high degree of MMTV internalization by the epithelium of 
the entire small intestine. 
analysis. Shortly after birth, the percentages of Vfl6 + CD4 § 
T  cells, and  as control Vfl14+CD4 +  T  cells were deter- 
mined. In these experiments, the pups were fed by infected 
mothers from birth. As early as 5 d after birth, a superan- 
tigen response was detectable in the Peyer's patches' Vfl6 § 
CD4 + T  cells but in no other lymphoid tissues.  This re- 
sponse was reproducible and was maximal between day 6 and 
9 after birth (see Fig. 2). After this activation, we observed 
a gradual reduction of the responsive Vfl6-bearing T  cells, 
approaching a near complete deletion in adult mice in all the 
lymphoid organs.  In  mesenteric lymph  nodes  (data  not 
Discussion 
Mucosal surfaces which contact the environment are con- 
tinuously threatened by invasive pathogens. Some microor- 
ganisms interact with M  cells in the FAE for their uptake 
(22,  25).  Whether MMTV exploits M cells to gain access 
to lymphoid follides has not been established.  Absorptive 
cells both in intestinal villi and in the FAE have been shown 
to take up MMTV (26, 27) and thus represent potential sites 
for viral entry. These cells are known to take up lumenal mac- 
romolecules by fluid phase endocytosis during the first 2 wk 
of life and direct them into the lysosomal degradative pathway. 
Figure 3.  Kinetics of appearance 
of reverse transcribed and integrated 
DNA of MMTV(SW) in different 
tissues.  Using  a  semiquantitative 
PCR assay,  we amplified DNA with 
oligonucleotides  detecting  either 
MMTV(SW) off specifically or all 
the endogenous and exogenous orf 
using primers detecting all MMTV 
(7,  15). The latter PCR amplifica- 
tion experiments indicated that the 
quantities of genomic DNA taken 
from different  organs at the indi- 
cated time points were comparable 
(data not shown). At different  time points after birth, when the babies  had received MMTV(SW)-infected milk from their mothers continuously, 
Peyer's patches (PP),  mesenteric lymph nodes (Mes), spleen (Spl),  thymus (Thy),  and peripheral lymph nodes (LN) were removed and DNA isolated. 
Small intestines after removal of Peyer's patches  (Gut)  as well as mammary glands (Marara) were tested using the same approach. 
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ileal or FAE enterocytes and enters the transcytotic pathway 
to be released in the interstitial  space remains  to be estab- 
lished.  Whatever  the mechanism  of entry,  it  appears  that 
MMTV has adopted a strategy to infect mice during the neo- 
natal period. Our study clearly indicates that early infection 
is restricted to Peyer's patch lymphocytes, in which viral DNA 
can already be detected 4 d after birth. This could reflect unique 
transepithelial transport properties of the FAE cells, or alter- 
natively, the presence of cells in the underlying tissue suscep- 
tible to infection. 
MMTV infection during the first 2 wk after birth has pro- 
found effects on the host immune  system. Presentation  of 
MMTV off superantigen  by B lymphocytes is required  to 
establish a productive infection (7, 8). Thereafter,  the virus 
is transported by lymphocytes and finally infects its target 
organ, the mammary gland, where the viral life cycle is com- 
pleted. Superantigen stimulation has so far only been studied 
in the peripheral lymphoid system of adult mice. Since the 
neonatal immune system is not mature yet, it was important 
to show whether in the case of physiologically infected neo- 
nates the superantigen exerts its effects in the Peyer's patches 
in the same way as for adult mice. 
As depicted in Fig. 1 of our study, we observe similar im- 
munolabeling patterns in the entire gut with MMTV(SW) 
as compared to published studies using MMTV(C3H). How- 
ever, PCR technology enables us to identify which cells carry 
viral DNA after infection. Despite the presence of MMTV 
particles in the whole intestinal epithelium,  MMTV DNA 
was found in the first 9 d exclusively in Peyer's patch lym- 
phocytes. A parallel FACS  |  analysis  of Peyer's patch and of 
different lymphoid organs draining the digestive tract showed 
that  a specific  superantigen response is restricted to Peyer's 
patches. This response was already detectable 5 d after birth. 
The other lymphoid organs did not show a superantigen- 
induced T  cell stimulation  even at later time points.  Viral 
DNA, however, was found at later stages first in the mesen- 
teric lymph nodes and thereafter in all the lymphoid organs, 
as well as in the mammary glands. The reasons for the lack 
of a superantigen stimulation in mesenteric and other lym- 
phoid organs draining the digestive tract are not clear.  Sev- 
eral hypotheses might explain our findings.  (a) The lack of 
activation might be due to the fact that uptake of the virus 
and then infection of B cells can only happen in the dome 
area whereas other gut epithelial cells might  degrade viral 
particles; (b) the microenvironment characteristic for Peyer's 
patches may be required for the superantigen response in the 
neonatal period;  and (c) the immune system in the patches 
might mature before the peripheral lymphoid organs. An ab- 
sence of a superantigen stimulation in nondraining lymphoid 
organs is also observed after footpad injection of MMTV in 
adult mice. 
MMTV-induced deletion is the most sensitive readout for 
infection (15). The injection of serum from MMTV-infected 
mice does not provoke superantigen-induced  deletion (28). 
This confirms the absence of detectable viremia. The sequential 
appearance  of MMTV(SW)  DNA  first  in  the  mesenteric 
lymph nodes and then in the peripheral  lymphoid organs, 
the gut mucosa, and the mammary glands most likely indi- 
cates the migration  of infected lymphocytes. 
The results we described here allow us to detect MMTV 
infection as early as 4  d  after birth.  This is in contrast  to 
the classical  in vivo infectivity model,  where it takes over 
6 mo to observe tumor development (3), or 1-3 mo to detect 
deletion or superantigen-reactive  T  cells  (15,  29). 
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